Biosimilar
ALTEOGEN’s researchers have many years od R&D and commercialization experience in biologics.
ALTEOGEN has been developing our own high expressive cell line, process(fermentation and purification) and analysis methods for Monoclonal Antibody biosimilars.
For MAB biosimilars, ALTEOGEN is collaborating with Brazilian and Japanese pharma companies.